These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 33143193)

  • 1. Sphingomyelinases and Liver Diseases.
    Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia.
    Fan J; Liu J; Liu J; Angel PM; Drake RR; Wu Y; Fan H; Koutalos Y; Crosson CE
    Exp Eye Res; 2022 Nov; 224():109250. PubMed ID: 36122624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
    Lightle SA; Oakley JI; Nikolova-Karakashian MN
    Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
    Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
    Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
    Taniguchi M; Okazaki T
    Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide signalling and the immune response.
    Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
    Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.
    Opreanu M; Lydic TA; Reid GE; McSorley KM; Esselman WJ; Busik JV
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3253-63. PubMed ID: 20071681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long- and short-term effects of thyroxine on sphingolipid metabolism in rat liver.
    Babenko NA
    Med Sci Monit; 2005 May; 11(5):BR131-138. PubMed ID: 15874883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6.
    Kim MH; Ahn HK; Lee EJ; Kim SJ; Kim YR; Park JW; Park WJ
    Int J Mol Med; 2017 Feb; 39(2):453-462. PubMed ID: 28035360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytosis and intracellular processing of BODIPY-sphingomyelin by murine CATH.a neurons.
    Nusshold C; Uellen A; Bernhart E; Hammer A; Damm S; Wintersperger A; Reicher H; Hermetter A; Malle E; Sattler W
    Biochim Biophys Acta; 2013 Dec; 1831(12):1665-78. PubMed ID: 23973266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Inositol Phosphosphingolipid Phospholipase C1, the Yeast Homolog of Neutral Sphingomyelinases in DNA Damage Response and Diseases.
    Tripathi K
    J Lipids; 2015; 2015():161392. PubMed ID: 26346287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling sphingomyelinases: which, where, how and why?
    Levade T; Jaffrézou JP
    Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells.
    Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M
    Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of sphingomyelin metabolism.
    Bienias K; Fiedorowicz A; Sadowska A; Prokopiuk S; Car H
    Pharmacol Rep; 2016 Jun; 68(3):570-81. PubMed ID: 26940196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingomyelin-degrading pathways in human cells role in cell signalling.
    Levade T; Andrieu-Abadie N; Ségui B; Augé N; Chatelut M; Jaffrézou JP; Salvayre R
    Chem Phys Lipids; 1999 Nov; 102(1-2):167-78. PubMed ID: 11001571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexachlorobenzene-induced alterations on neutral and acidic sphingomyelinases and serine palmitoyltransferase activities. A time course study in two strains of rats.
    Billi de Catabbi SC; Setton-Advruj CP; Sterin-Speziale N; San Martín de Viale LC; Cochón AC
    Toxicology; 2000 Aug; 149(2-3):89-100. PubMed ID: 10967406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
    Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
    J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
    Claus RA; Dorer MJ; Bunck AC; Deigner HP
    Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal expression profiles of ceramide and ceramide-related genes in wild-type and mPer1/mPer2 double knockout mice.
    Jang YS; Kang YJ; Kim TJ; Bae K
    Mol Biol Rep; 2012 Apr; 39(4):4215-21. PubMed ID: 21773940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipid changes in mouse brain and plasma after mild traumatic brain injury at the acute phases.
    Mondal K; Del Mar NA; Gary AA; Grambergs RC; Yousuf M; Tahia F; Stephenson B; Stephenson DJ; Chalfant CE; Reiner A; Mandal N
    Lipids Health Dis; 2024 Jun; 23(1):200. PubMed ID: 38937745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.